HUC3-053

· Huons Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HUC3-053, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of HUC3-053 in Patients With Dry Eye Syndrome [Phase 3]